STTK Q4 2024 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$291M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$20M

Net Income

-$19M

EPS (Diluted)

$-0.37

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$91M

Total Liabilities

$11M

Stockholders' Equity

$80M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$714,000	-100.0%
Gross Profit	$0	-$267,000	+100.0%
Operating Income	-$20M	-$19M	-3.6%
Net Income	-$19M	-$18M	-5.6%